ANKAR

gene
On this page

Also known as FLJ25415

Summary

ANKAR (ankyrin and armadillo repeat containing, HGNC:26350) is a protein-coding gene on chromosome 2q32.2, encoding Ankyrin and armadillo repeat-containing protein (Q7Z5J8).

Predicted to be located in membrane.

Source: NCBI Gene 150709 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 301 total — 7 pathogenic, 1 likely-pathogenic
  • MANE Select transcript: NM_001378068

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26350
Approved symbolANKAR
Nameankyrin and armadillo repeat containing
Location2q32.2
Locus typegene with protein product
StatusApproved
AliasesFLJ25415
Ensembl geneENSG00000151687
Ensembl biotypeprotein_coding
OMIM609803
Entrez150709

Gene structure

Transcript identifiers

Ensembl transcripts: 10 — 4 protein_coding_CDS_not_defined, 3 protein_coding, 2 nonsense_mediated_decay, 1 retained_intron

ENST00000313581, ENST00000433782, ENST00000441800, ENST00000461516, ENST00000464687, ENST00000467927, ENST00000474303, ENST00000476208, ENST00000520309, ENST00000684021

RefSeq mRNA: 2 — MANE Select: NM_001378068 NM_001378068, NM_144708

CCDS: CCDS33351

Canonical transcript exons

ENST00000684021 — 23 exons

ExonStartEnd
ENSE00001772368189676456189677091
ENSE00002258738189730495189730601
ENSE00002279237189733107189733229
ENSE00002324359189728267189728420
ENSE00002462463189694981189695161
ENSE00002462766189696150189696369
ENSE00002467490189692255189692418
ENSE00002471742189693074189693177
ENSE00002474032189705023189705224
ENSE00002523861189711049189711153
ENSE00002523920189727856189728097
ENSE00002527278189720619189720787
ENSE00003551438189706938189707146
ENSE00003563557189689527189689964
ENSE00003569856189738565189738682
ENSE00003587008189728660189728821
ENSE00003626412189744742189744788
ENSE00003656653189743275189743474
ENSE00003660070189741342189741451
ENSE00003670923189737683189737841
ENSE00003679785189719572189719813
ENSE00003918477189746380189746647
ENSE00003919820189674670189674830

Expression profiles

Bgee: expression breadth ubiquitous, 163 present calls, max score 93.70.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.8167 / max 64.1693, expressed in 1426 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
242562.29111069
242541.9225719
242550.5783279
242530.02493

Top tissues by expression

248 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
calcaneal tendonUBERON:000370193.70gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047381.27gold quality
left ovaryUBERON:000211980.89gold quality
tibial nerveUBERON:000132380.35gold quality
popliteal arteryUBERON:000225080.08gold quality
tibial arteryUBERON:000761080.06gold quality
body of uterusUBERON:000985380.05gold quality
sural nerveUBERON:001548879.84gold quality
descending thoracic aortaUBERON:000234579.76gold quality
right uterine tubeUBERON:000130279.68gold quality
right ovaryUBERON:000211879.44gold quality
left testisUBERON:000453379.19gold quality
aortaUBERON:000094779.17gold quality
right testisUBERON:000453479.14gold quality
body of pancreasUBERON:000115079.08gold quality
endocervixUBERON:000045878.82gold quality
ascending aortaUBERON:000149678.50gold quality
thoracic aortaUBERON:000151578.49gold quality
right lobe of thyroid glandUBERON:000111978.44gold quality
adrenal tissueUBERON:001830378.33gold quality
left coronary arteryUBERON:000162678.31gold quality
right coronary arteryUBERON:000162577.87gold quality
muscle layer of sigmoid colonUBERON:003580577.87gold quality
left lobe of thyroid glandUBERON:000112077.84gold quality
mucosa of stomachUBERON:000119977.64gold quality
esophagogastric junction muscularis propriaUBERON:003584177.62gold quality
lower esophagus muscularis layerUBERON:003583377.39gold quality
ectocervixUBERON:001224977.37gold quality
lower esophagusUBERON:001347377.36gold quality
testisUBERON:000047377.07gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no5.48

Regulation

Is transcription factor: no

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_rerioankarENSDARG00000000516
mus_musculusAnkarENSMUSG00000039342
rattus_norvegicusAnkarENSRNOG00000003991
drosophila_melanogasterarmFBGN0000117
caenorhabditis_eleganshmp-2WBGENE00001979

Paralogs (4): ARMC3 (ENSG00000165309), CTNNB1 (ENSG00000168036), ODAD2 (ENSG00000169126), JUP (ENSG00000173801)

Protein

Protein identifiers

Ankyrin and armadillo repeat-containing proteinQ7Z5J8 (reviewed: Q7Z5J8)

All UniProt accessions (2): Q7Z5J8, E7EWS1

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Membrane.

Tissue specificity. Ubiquitously expressed with highest level in pancreas and lowest in skeletal muscle.

Isoforms (4)

UniProt IDNamesCanonical?
Q7Z5J8-11, FLJ25415-2Pyes
Q7Z5J8-22
Q7Z5J8-33
Q7Z5J8-44

RefSeq proteins (2): NP_001364997, NP_653309 (=MANE)

Domains & families (InterPro)

IDNameType
IPR000225ArmadilloRepeat
IPR002110Ankyrin_rptRepeat
IPR011989ARM-likeHomologous_superfamily
IPR016024ARM-type_foldHomologous_superfamily
IPR036770Ankyrin_rpt-contain_sfHomologous_superfamily
IPR043379ANKARFamily

Pfam: PF00514, PF12796

UniProt features (29 total): repeat 11, splice variant 9, sequence conflict 5, sequence variant 2, chain 1, transmembrane region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q7Z5J8-F184.790.53

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 15 (showing top): IGLV5_37_TARGET_GENES, PAX3_TARGET_GENES, UBN1_TARGET_GENES, ZNF711_TARGET_GENES, BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP, MANNO_MIDBRAIN_NEUROTYPES_HGABA, LHX2_TARGET_GENES, OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_DN, GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_DN, chr2q32, ZNF320_TARGET_GENES, GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN, GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_IRES_GFP_UP, GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TCONV_UP, GSE37532_WT_VS_PPARG_KO_LN_TREG_DN

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (1): membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
binding1
cellular anatomical structure1

Protein interactions and networks

STRING

564 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ANKAROSGEPL1Q9H4B0932
ANKARTMF1P82094820
ANKARNEMP2A6NFY4661
ANKARORMDL1Q9P0S3605
ANKARWDR75Q8IWA0511
ANKARDIRC1Q969H9507
ANKARIGFALSP35858482
ANKARNFATC2Q13469465
ANKARSLC68A1Q14CX5455
ANKARPMS1P54277452
ANKARUSF3Q68DE3447
ANKARC17orf67Q0P5P2446
ANKARFBXL15Q9H469440
ANKARAKAP19P0C876432
ANKARUBXN2BQ14CS0425

IntAct

2 interactions, top by confidence:

ABTypeScore
IQCB1PCP4L1psi-mi:“MI:0914”(association)0.350

BioGRID (7): ANKAR (Affinity Capture-RNA), SNRPB (Cross-Linking-MS (XL-MS)), MICAL3 (Cross-Linking-MS (XL-MS)), RPL31 (Cross-Linking-MS (XL-MS)), ANKAR (Cross-Linking-MS (XL-MS)), EEF1G (Cross-Linking-MS (XL-MS)), ANKAR (Affinity Capture-MS)

ESM2 similar proteins: A1Z8X3, A2RT91, A5D8W1, A6NKT7, B0CM26, B0VXE6, B1WBT0, C9JQI7, F4JY37, G5ED39, H2QII6, O01510, O08662, O14715, O43065, O94324, P0DJD0, P0DJD1, P12798, P32333, P40955, P45964, P49792, Q01015, Q03280, Q03569, Q0IEK6, Q10122, Q13535, Q17551, Q177G4, Q18508, Q21920, Q4UKJ5, Q5K6N0, Q5S007, Q60J38, Q70PP2, Q756G2, Q7TSH2

Diamond homologs: A2RT91, Q3SX45, Q7Z5J8, A6NK59, P0C927, Q08DV6, Q3V096, Q58CT0, Q5U2S6, Q8C6Y6, Q8HXA6, Q8K0L0, Q8N9B4, Q8VHS6, Q8WXK1, Q96Q27, Q9WV72, Q9WV74, Q9Y575, Q9Y576

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

301 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic7
Likely pathogenic1
Uncertain significance221
Likely benign15
Benign13

Top pathogenic / likely-pathogenic (8)

Variant IDHGVSClassification
146486GRCh38/hg38 2q32.2(chr2:188947503-189689613)x1Pathogenic
146616GRCh38/hg38 2q32.1-33.1(chr2:186027472-201059372)x1Pathogenic
149200GRCh38/hg38 2q31.3-32.3(chr2:181758701-192015392)x1Pathogenic
153288GRCh38/hg38 2q31.2-32.3(chr2:177827730-195125329)x1Pathogenic
1807826GRCh37/hg19 2q32.1-33.1(chr2:187152754-199960525)x1Pathogenic
58771GRCh38/hg38 2q31.2-33.1(chr2:177874070-198525492)x1Pathogenic
977790GRCh37/hg19 2q32.2-33.1(chr2:190345272-200212289)Pathogenic
979391GRCh37/hg19 2q32.1-33.1(chr2:188294864-197731939)x3Likely pathogenic

SpliceAI

4588 predictions. Top by Δscore:

VariantEffectΔscore
2:189689625:GCT:Gdonor_gain1.0000
2:189692250:T:TAacceptor_gain1.0000
2:189705220:GCTGA:Gdonor_gain1.0000
2:189705221:C:Gdonor_gain1.0000
2:189705225:G:GGdonor_gain1.0000
2:189707042:G:GTdonor_gain1.0000
2:189752651:A:ACdonor_gain1.0000
2:189752652:C:CCdonor_gain1.0000
2:189753910:ACTT:Adonor_loss1.0000
2:189753911:CTTA:Cdonor_loss1.0000
2:189753912:TTA:Tdonor_loss1.0000
2:189753913:TACCA:Tdonor_loss1.0000
2:189753914:A:ACdonor_gain1.0000
2:189753914:ACCA:Adonor_loss1.0000
2:189753915:C:CAdonor_loss1.0000
2:189753915:C:CCdonor_gain1.0000
2:189753915:CCAGT:Cdonor_gain1.0000
2:189754061:ATACC:Aacceptor_loss1.0000
2:189754063:ACCT:Aacceptor_loss1.0000
2:189754066:T:Cacceptor_loss1.0000
2:189754259:T:TAdonor_gain1.0000
2:189755408:C:CAdonor_gain1.0000
2:189755422:AAGT:Adonor_gain1.0000
2:189755425:T:TAdonor_gain1.0000
2:189689518:A:AGacceptor_gain0.9900
2:189689519:T:Gacceptor_gain0.9900
2:189689522:TGAA:Tacceptor_loss0.9900
2:189689525:A:AGacceptor_gain0.9900
2:189689525:AGG:Aacceptor_loss0.9900
2:189689526:G:GGacceptor_gain0.9900

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000017156 (2:189762886 G>A,T), RS1000081282 (2:189757267 A>G), RS1000194293 (2:189760565 G>T), RS1000234123 (2:189701965 A>G), RS1000272757 (2:189724144 A>C), RS1000289538 (2:189702238 A>C,G), RS1000333517 (2:189700957 T>A), RS1000501457 (2:189737389 A>G), RS1000531709 (2:189673750 A>G,T), RS1000538019 (2:189757769 C>A,T), RS1000591391 (2:189756153 T>G), RS1000595148 (2:189675090 C>G,T), RS1000681241 (2:189680019 C>A), RS1000713176 (2:189681817 T>C), RS1000744355 (2:189674530 C>T)

Disease associations

OMIM: gene MIM:609803 | disease phenotypes: MIM:613796, MIM:614162, MIM:614892, MIM:612313

GenCC curated gene-disease

Mondo (4): immunodeficiency 31B (MONDO:0013427), autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome (MONDO:0013599), Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency (MONDO:0013956), chromosome 2q32-q33 deletion syndrome (MONDO:0012864)

Orphanet (5): Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency (Orphanet:319595), Susceptibility to viral and mycobacterial infections due to STAT1 deficiency (Orphanet:391311), STAT1-related autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome (Orphanet:391487), 2q32q33 deletion syndrome (Orphanet:251019), SATB2-associated syndrome due to a pathogenic variant (Orphanet:576283)

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST001762_565Obesity-related traits6.000000e-06
GCST002578_1Ferritin levels2.000000e-10

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0003939energy intake
EFO:0004459ferritin measurement

MeSH disease descriptors (1)

DescriptorNameTree numbers
C567350Chromosome 2q32-Q33 Deletion Syndrome (supp.)

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

25 total (human), top 25 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneaffects methylation, decreases methylation2
GSK-J4decreases expression1
triphenyl phosphateaffects expression1
dimethylselenideincreases expression, increases oxidation1
tris(1,3-dichloro-2-propyl)phosphateincreases expression1
sodium arseniteincreases expression1
butyraldehydedecreases expression1
perfluorooctanoic aciddecreases expression1
di-n-butylphosphoric acidaffects expression1
perfluorooctane sulfonic aciddecreases expression1
perfluoro-n-nonanoic aciddecreases expression1
perfluorohexanesulfonic aciddecreases expression1
jinfukangaffects cotreatment, increases expression1
2,3,5-trichloro-6-phenyl-(1,4)benzoquinoneincreases expression1
Sunitinibincreases expression1
Acetaminophenincreases expression1
Cadmiumincreases abundance, increases expression1
Cisplatinaffects cotreatment, increases expression1
Melphalandecreases expression1
Aflatoxin B1decreases methylation1
Hydroxyl Radicalincreases expression, increases oxidation1
Cadmium Chlorideincreases abundance, increases expression1
Okadaic Aciddecreases expression1
Acrylamideincreases expression1
S-Nitrosoglutathioneincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.